MDM2 overexpression not only promotes cancer progression by inhibiting p53 but also acts as a pro-angiogenic stimulus through the upregulation of matrix metallopeptidase 9 and tumor necrosis factor-alpha [12]. The gene discussed is TP53; the disease is cancer.